Garvieacin Q, a novel class II bacteriocin from Lactococcus garvieae BCC 43578.
Lactococcus garvieae BCC 43578 produces a novel class II bacteriocin, garvieacin Q (GarQ), 70 amino acids in length and containing a 20-amino-acid N-terminal leader peptide. It is cleaved at the Gly-Gly site to generate the mature GarQ (5,339 Da), which is especially inhibitory against Listeria monocytogenes ATCC 19115 and other L. garvieae strains.
National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Thailand. amonlaya.tos@biotec.or.th
Amonlaya
A
Tosukhowong
Takeshi
T
Zendo
Wonnop
W
Visessanguan
Sittiruk
S
Roytrakul
Laphaslada
L
Pumpuang
Janthima
J
Jaresitthikunchai
Kenji
K
Sonomoto
D001430:Bacteriocins / Q000096:biosynthesis* / Q000737:chemistry / Q000235:genetics* / Q000494:pharmacology; D017045:Lactococcus / Q000235:genetics* / Q000378:metabolism*; D008089:Listeria monocytogenes / Q000187:drug effects / Q000254:growth & development; D008969:Molecular Sequence Data; D008970:Molecular Weight; D017422:Sequence Analysis, DNA
D001430:Bacteriocins